1. Lin CW, Manshouri T, Jilani I, et al. Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome. Leuk Res 2002;26:551-559.

2. Oliveira GB, Pereira FG, Metze K, Lorand-Metze I. Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters. Cytometry 2001;46(6):329-335.

3. Faguet GB, Agee JF, Marti GE. Clone emergence and evolution in chronic lymphocytic leukemia: Characterization of clinical, laboratory, and immunophenotypic profiles of 25 patients. Leuk Lymphoma 1992;6:345-356.

4. Faguet GB. Chronic lymphocytic leukemia: An updated review J Clin Oncol 1994;12(9):1974-1990.

5. Rai KR, Han T. Prognostic factors and clinical staging in chronic lymphocytic leukemia. Hematol Oncol Clin North Am 1990;4:447-456.

6. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from multivariate survival analysis. Cancer 1981;48:198-207.

7. Montserrat E, Vinolas N, Reverter JC, Rozman C. Natural history of chronic lymphocytic leukemia: On the progression and prognosis of early stages. Nouv Rev Fr Hematol 1988;30:459-461.

8. Tsiodras S, Samonis G, Keating MJ, Kontoyiannis DP. Infection and immunity in chronic lymphocytic leukemia. Mayo Clin Proc 2000;75:1039-1054.

9. Fairley GH, Scott RB. Hypogammaglobulinemia in chronic lymphocytic leukemia. BMJ 1961;2:290-294.

10. Morrison VA, Rai KR, Peterson BL, et al. Impact of therapy with chlorambucil, Fludarabine, or Fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study of Cancer and Leukemia Group B9011. J Clin Oncol 2001;19:3611-3621.

11. Long JC, Aisenberg AC. Richter's syndrome: a terminal complication of chronic lymphocytic leukemia with distinct clinical pathologic features. Am J Clin Pathol 1975;63:7786-7795.

12. Kjeldberg CR, Marty J. Prolymphocytic transformation of chronic lymphocytic leukemia. Cancer 1981;48: 2447-2457.

13. Frenkel EP, Ligler FS, Graham MS, Hernandez JA, Kettman JR Jr, Smith RG. Acute lymphocytic leukemia transformation of chronic lymphocytic leukemia: substantiation by flow cytometry. Am J Hematol 1981;10:391-398.

14. Brouet JC, Fermand JP, Laurent G, et al. The association of chronic lymphocytic leukemia and multiple myeloma: a study of eleven patients. Br J Haematol 1985;59:55-66.

15. Greene MH, Hover RN, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia—a possible immunologic mechanism. J Natl Cancer Inst 1978;61:337-340.

16. Travis LB, Curtis RE, Hankey BF, Fraumeni JF Jr. Second cancers in patients with chronic lymphocytic leukemia. Natl Cancer Inst 1992;84:1422-1427.

17. Richter MN. Generalized reticular cell sarcoma of lymph nodes associated with lymphocytic leukemia. Am J Pathol 1928;4:285-292.

18. Lortholary P, Boiron M, Ripault P, et al. Leucemie lymphoide chronique secondairement associee a une reticulopathie maligne, syndrome de Richter. Nouv Rev Fr Hemat 1964;78:621-644.

19. Harousseau JL, Flandrin G, Tricot G, et al. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer 1981;48:1302-1308.

20. Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome). Pathol Intl 2000;50:636-643.

21. Robertson LE, Pugh W, O'Brien S, et al. Richter's syndrome: a report on 39 patients. J Clin Oncol 1993;11: 1985-1989.

22. Han T, Henderson ES, Emrich LJ, Sandberg AA. Prognostic significance of karyotypic abnormalities in B cell chronic lymphocytic leukemia: an update. Semin Hematol 1987;24:257-263.

23. Foucar K, Rydell RE. Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980;46:116-134.

24. Han T, Henderson ES, Emrich LJ, Sandberg AA. Richter syndrome with emphasis on large-cell non-Hodgkin's lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia. Neoplasma 1997;44:63-68.

25. Fayad L, Roberson LA, O'Brien S, et al. Hodgkin's disease variant of Richter's syndrome: experience at a single institution. Leuk Lymphoma 1996;23:333-337.

26. Giles FJ, O'Brien S, Keatin MJ. Chronic lymphocytic leukemia in (Richter's) transformation. Semin Oncol 1998;25:117-125.

27. Hebert J, Jonveaux P, d'Agay MF, Berger R. Cytogenetic studies in patients with Richter's syndrome. Cancer Genet Cytogenet 1994;73:65-68.

28. Sanderg AA, Chen Z. FISH analysis. In: Faguet GB, ed. Hematologic Malignancies: Methods and Techniques. Humana, Totowa, NJ, 2001, pp. 19-42.

29. Baudis M, Bentz M. Comparative genomic hybridization for the analysis of leukemias and lymphomas. In: Faguet GB, ed. Hematologic Malignancies: Methods and Techniques. Humana, Totowa, NJ, 2001, pp. 43-64.

30. Hildgenfeld E, Padilla-Nash H, Haas OA, Serve H, Schröck E, Ried T. Spectral karyotype (SKY) of hematologis malignancies. In: Faguet GB, ed. Hematologic Malignancies: Methods and Techniques. Humana, Totowa, NJ, 2001, pp. 65-69.

31. Arranz E, Martinez B, Richart A, et al. Increased C-MYC oncogene copy number detected with combined modified comparative genomic hybridization and FISH analysis in a Richter syndrome case with complex karyotype. Cancer Genet Cytogenet 1998;106:80-83.

32. Cuneo A, De Angeli C, Roberti MG, et al. Richter's syndrome in a case of atypical chronic lymphocytic leukemia with the (11;14)(q13;132): role for a p53 exon 7 gene mutation. Br J Haematol 1996;92:375-381.

33. Bea S, Lopez-Guillermo A, Ribas M, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndroem). Am J Pathol 2002;161:957-968.

34. Faguet GB, ed. Hematologic Malignancies: Methods and Techniques. Humana, Totowa, NJ, 2001.

35. Foon KA, Thiruvengadam R, Saven A, Bernstein ZP, Gale RP. Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med 1993;119:63-73.

36. Besudo A, Kipps TJ. Origin of high-grade lymphomas in Richter's syndrome. Leuk Lymphoma 1995;18:367-372.

37. Schots R, Dehou MF, Jochmans K, et al. Southern blot analysis in a case of Richter's syndrome. Evidence for a postarrangement heavy chain gene deletion associated with the altered phenotype. Am J Clin Pathol 1991;95:571-577.

38. Miyamura K, Osada H, Yamauchi T, et al. Origin of neoplastic B-cells with different immunoglobulins light chains in a patient with Richter's syndrome. Cancer 1990;66:14-144.

39. Nakamine H, Masih AS, Sanger WG, et al. Richter's syndrome with different immunoglobulins light chain types. Molecular and cytogenetic features indicate a common clonal origin. Am J Clin Pathol 1992;97:656-663.

40. Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ. Common clonal origin of chronic lymphocytic leukemia and high grade lymphoma in Richter's syndrome. Blood 1993;82:3141-3147.

41. Ostrowski M, Minden M, Wang C, Bailey D. Immunophenotypic and gene probe analysis of a cased of Richter's syndrome. Am J Clin Pathol 1989;91:215-221.

42. Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 1994;83:1363-1372.

43. Matolcsy A, Schattner EJ, Knowles DM, Casali P. Clonal evolution of B cells in transformation from low- to highgrade lymphoma. Eur J Immunol 1999;29:1253-1264.

44. Parrens M, Sawan B, Dubus P, et al. Primary digestive Richter's syndrome. Mod Pathol 2001;14:452-457.

45. Dabaja BS, O'Brien SM, Kantarjian HM, et al. Fractionated cyclophosphamide, Vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome. Leuk Lymphoma 2001;42:329-337.

46. McBride NC, Cavenagh JD, Ward MC, et al. Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, Vincristine and prednisosne (COP-X) as salvage therapy in poor-prognosis non-Hodgkin's lymphoma. Leuk Lymphoma 2001;42:89-98,2001.

47. Schipper H. Treating cancer: is kill cure? Ann Acad Med Singapore 1994;23:382-386.

48. Hisada M, Biggar RJ, Greene MH, Fraumeni JF, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood 2001;98:1979-1981.

49. Cheson BD. Recent advances in the treatment of chronic lymphocytic leukemia. Oncology 1990;4:71-84.

50. Morrison VA, Rai KR, Peterson B, et al. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, Cancer and Leukemia Group B 9011. J Clin Oncol 2002;20:3878-3884.

51. Faguet GB. Mechanisms of lymphocyte activation: the role of suppressor cells in the proliferative responses of chronic lymphocytic leukemia lymphocytes. J Clin Invest 1979;63:67-74.

52. Bartik MM, Welker D, Kay NE. Impairments in immune function in B cell chronic lymphocytic leukemia. Semin Oncol 1998;25:27-33.

53. Linet MS, Cartwright RA. The leukemias. In: Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention, 2nd ed. Oxford University Press, New York, 1996, pp. 841-892.

54. Travis LB, Curtis RE, Glimelius B, et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995;87:524-530,.

55. Hoover R. Effects of drugs—Immunosuppression. In: Hiatt HH, Watson JD, Winsten JA, eds. Origins of Human Cancer. Book A. Incidence of Cancer in Humans. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1977, pp. 369-379.

56. Swerdlow AJ, Schoemaker MJ, Allerton R, et al. Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. J Clin Oncol 2001;19:1610-1618.

57. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982;306:913-918.

58. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 1984;311:565-570.

59. Beral V, Newton R. Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr 1998;23:1-6.

60. Boshoff C, Weiss R. AIDS-related malignancies. Natl Rev Cancer 2002;2:373-382.

61. Mueller BU, Pizzo PA. Cancer in children with primary or secondary immunodeficiencies. J Pediatr 1995;126: 1-10.

62. Gatti RA, Good RA. Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 1971; 28:89-98.

63. Berk PD, Goldberg JD, Silverstein MN, et al. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N Engl J Med 1981;304:441-447.

64. Polycythemia Vera Study Group minutes, 1987.

65. Cellai E, Magrini SM, Masala G, et al. The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hospital. Int J Radiat Oncol Biol Phys 2001; 49:1327-1337.

66. van Leeuwen FE, Klokman WJ, Veer MB, et al. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 2000;18:487-497.

VTI Familial and Juvenile

Chronic Lymphocytic Leukemia

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook

Post a comment